Imaging—particularly MRI and high-resolution ultrasound—combined with serum tumor markers (LDH, hCG, AFP) and, when appropriate, immunohistochemical evaluation of OCT3/4 in gonadal biopsies, can help identify early neoplastic changes. This evidence concerns the gene AFP and neoplasm.